7799 Herong Tech: IND Application for B10 L-BPA Injection
NQ Score
52/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Herong Tech has filed an Investigational New Drug (IND) application with the TFDA for its B10 L-BPA injection, targeting recurrent locally advanced or metastatic triple-negative breast cancer to evaluate the efficacy and safety of BNCT.
AI Analysis
Frequently Asked Questions
- Q: What is BNCT?
- A: Boron Neutron Capture Therapy, a targeted radiation therapy for cancer.